{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-094789","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2025-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.072573+00:00","generated_at":"2026-05-18T08:54:41.517008+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Revelation Biosciences effects 1-for-3 reverse stock split; PRIME Phase 1b enrollment expected to complete July 2025","bullets":["1-for-3 reverse stock split effective July 7, 2025; post-split shares ~1,534,599.","Split intended to regain Nasdaq minimum bid price compliance; CUSIP changed to 76135L705.","PRIME Phase 1b study of Gemini in CKD patients: enrollment expected to complete July 2025; topline data anticipated shortly after."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-094789","json":"https://secwatch.observer/filing/0000950170-25-094789.json","markdown":"https://secwatch.observer/filing/0000950170-25-094789.md","text":"https://secwatch.observer/filing/0000950170-25-094789.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025094789/0000950170-25-094789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025094789/revb-20250707.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:54:41.517008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac5b2e266ca4309eb14b5ae0be548c1f12c81f64","claim":"REVELATION BIOSCIENCES, INC.: Filed Certificate of Amendment to effect a 1-for-3 reverse stock split (effective 2025-07-07).","evidence_excerpt":"the Company filed a Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) effective on July 7, 2025, which effected a 1-for-3 reverse stock split as of 12:01 a.m. Eastern Standard Time on July 7, 2025","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025094789/0000950170-25-094789-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-07-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}